AOD-9604 in 2026: The Fat-Loss Peptide's Real Trial Data, Mechanism & GLP-1 Comparison

AOD-9604 (HGH Fragment 176-191) ran through six placebo-controlled human trials and 900+ participants -- here's what the data actually showed, how it compares mechanistically to GLP-1 agonists, and what researchers reference for dosing today.